Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: IDEXX Laboratories Inc., 3 years.
IDEXX Laboratories Inc.
Director
Crescent Biopharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 29, 2024 | Crescent Biopharma Inc. | Grant or award | +5,209 | $3.00 | $15,627 |
| Jan 30, 2024 | IDEXX Laboratories Inc. | Grant or award | +14 | $521.03 | $7,294 |
| Oct 30, 2023 | IDEXX Laboratories Inc. | Grant or award | +19 | $396.39 | $7,531 |
| Jul 28, 2023 | IDEXX Laboratories Inc. | Grant or award | +14 | $552.78 | $7,739 |
| May 10, 2023 | Crescent Biopharma Inc. | Open-market purchase | +30,000 | $1.56 | $46,800 |
| Apr 28, 2023 | IDEXX Laboratories Inc. | Grant or award | +13 | $492.16 | $6,398 |
| Feb 16, 2023 | IDEXX Laboratories Inc. | Option exercise | +2,187 | $206.62 | $451,878 |
| Feb 16, 2023 | IDEXX Laboratories Inc. | Open-market sale | −2,187 | $511.68 | $1,119,044 |
| Jan 30, 2023 | IDEXX Laboratories Inc. | Grant or award | +14 | $482.95 | $6,761 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.